Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet Achieves Key Milestones to Support its Transition to Direct Operations in Europe on July 1, 2018
High-Caliber Team in Place Throughout Key Geographies Partnerships Established with Experienced European Companies for Customer Care and Logistics BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--May 3, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the leader in tubeless insulin
View HTML
Toggle Summary Insulet Establishes Two Significant Commercial Partnerships to Support its European Expansion
BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--May 1, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has entered into partnerships with two
View HTML
Toggle Summary Insulet to Announce First Quarter 2018 Financial Results on May 3, 2018
BILLERICA, Mass. --(BUSINESS WIRE)--Apr. 5, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the first quarter of 2018 on May
View HTML
Toggle Summary Insulet to Share Omnipod Clinical Data at Three Major European National Diabetes Congresses
Strong Presence at National Professional Diabetes Congresses in the UK , France and Germany Demonstrates Insulet’s Commitment to the European Diabetes Community BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 14, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the leader in tubeless
View HTML
Toggle Summary Insulet Expands Access to Omnipod® as an In-Network Provider with UnitedHealthcare
Insulet Expands Access to Omnipod® as an In-Network Provider with UnitedHealthcare – For more information, please see the following link .
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conferences
BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 28, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet ), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences: This press release
View HTML
Toggle Summary Insulet Reports Fourth Quarter Revenue of $130.5 Million, Up 26%, and Gross Margin Up 210 Basis Points, Exceeding Expectations
Full Year 2017 Revenue of $463.8 Million , Up 26%, and Gross Margin Up 230 Basis Points Full Year 2018 Expected Revenue Growth of 21% to 25% BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 21, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump
View HTML
Toggle Summary Insulet Has Strong Presence at the International ATTD Congress; Presents Positive Study Results for Its Omnipod Horizon™ Hybrid Closed-Loop System
Significant Presence at ATTD Congress Demonstrates Insulet’s Future Commitment to the Diabetes Community in Europe Studies Show Exceptional Potential for the Omnipod Horizon System to Maintain Stable Blood Glucose Levels after Specific Meal and Exercise Challenges BILLERICA, Mass.
View HTML
Toggle Summary Insulet Corporation to Announce Fourth Quarter and Full Year 2017 Financial Results on February 21, 2018
BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 29, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year
View HTML
Toggle Summary Medicare Part D (Prescription Drug) Plans May Now Cover Omnipod®
Significantly Expands Access to Omnipod and Provides a Pathway to Broader Medicaid Coverage BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 8, 2018-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conference
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco,
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conference
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference in New York City ,
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conference
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the Jefferies 2017 London Healthcare Conference on November 15, 2017 , at
View HTML
Toggle Summary Insulet Announces Pricing of Convertible Senior Notes Due 2024
Proceeds for General Corporate Purposes, Including Repurchase of a Portion of Outstanding 2% Convertible Senior Notes Due 2019 and Investment in Manufacturing Operations and International Expansion BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), a
View HTML
Toggle Summary Insulet Announces Private Offering of Convertible Senior Notes
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ:PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced its intention to offer, subject to market and other conditions, $300 million
View HTML